Business Wire

CO-OPTIV-SECURITY

23.9.2019 10:07:05 CEST | Business Wire | Press release

Share
Businesses are Prioritising Cybersecurity Above All Else, Optiv Security Report Finds

With the rise of the data breach epidemic, and the imposition of comprehensive privacy regulations and significant legislation requirements, cybersecurity has become a tier-one business risk. As a result, the chief information security officer’s (CISO) role in a business has dramatically increased in value. In fact, 64 percent of businesses now prioritise cybersecurity above all else, even if it slows some users’ productivity down, according to a new research report from Optiv Security . The report, “The State of the CISO,” takes an in-depth look at the approach to cybersecurity taken by CISOs, CSOs and senior IT decision makers, the strategies they have in place and their experience of data breaches.

Cybersecurity becomes a business priority

The research found that the importance of cybersecurity is now better understood by business executives and board members. In fact, 96 percent of respondents indicated they are taking a more strategic approach to cybersecurity as a result of being greater aligned with business leaders.

“Some organisations are further along this evolutionary curve than others, but without business’ buy-in to a cybersecurity program, CISOs will undoubtedly struggle to keep their organisations safe from looming cyber threats,” said Andrzej Kawalec, Optiv’s director of strategy and technology, Europe. “We are seeing a significant shift in the industry, whereby cybersecurity is now a business issue. CISOs are being regarded as an important part of major business initiatives such as next-generation digital transformation, which has led to more funding for cyber programs. The board now understands that a major security or compliance miscue can derail a business.”

When it comes to the approach to cybersecurity, the research found that 66 percent of IT security decision makers felt greater awareness of security risks within the IT function has had a significant impact on currently existing cybersecurity policies. Compliance with external standards such as GDPR follows closely behind at 56 percent, but basic functions like vulnerability and patching is only prioritised by 32 percent of respondents. Employee education was deemed a top priority by 58 percent of respondents, as was simplifying infrastructure (54 percent) and aligning security with development operations to create a DevSecOps model (47 percent).

“It is concerning in light of the fact that, by some estimates, unpatched vulnerabilities account for more than half of all data breaches,” continued Kawalec. “By getting the basic functions of cybersecurity right, IT decision makers can drastically improve their chances of defending against a cyber-attack, since unpatched software is often cited as the most common cause of data breaches.”

The greatest security threats

The research also identified that 31 percent of respondents believe that organized crime and politically motivated acts are seen as the greatest threats to cybersecurity, while 28 percent believe this to be hacktivists. Insider threats are seen as critical by 26 percent and just 15 percent of respondents cited third parties as a threat to their cybersecurity. To deal with cybersecurity threats, 92 percent of respondents have an incident response plan in place, but rehearsing this plan is lagging, with 44 percent of businesses stating they only rehearse once a year or less.

The report finds that breaches still seem to serve as a wake-up call for organizations, with 39 percent of businesses implementing changes in their security program only after an incident. While 65 percent cited that recovery from the breach was well coordinated and successful, over a third (35 percent) reported that recovery costs were still higher than it would have cost to invest in better breach defence.

To read the full report, please visit Optiv’s website .

Methodology

Optiv launched an independent research series to discover how IT decision makers approach cybersecurity. To produce its research and resulting report, Optiv worked with London-based research agency, Loudhouse. Loudhouse is an independent agency that specializes in technology and B2B research for global brands.

Loudhouse conducted online interviews with 100 US- and 100 UK-based CISOs, CSOs and Senior IT decision makers at enterprise businesses (between 500 and 5000+ employees), to understand their approach to cybersecurity, the strategies they have in place, and their experience of data breaches.

Follow Optiv
Twitter: www.twitter.com/optiv
LinkedIn: www.linkedin.com/company/optiv-inc
Facebook: www.facebook.com/optivinc
YouTube: https://www.youtube.com/c/OptivInc
Blog: https://www.optiv.com/explore-optiv-insights/blog

Optiv Security: Who Secures Your Insecurity?
Optiv is a security solutions integrator – a global, “one-stop” trusted partner with a singular focus on cybersecurity. Our end-to-end cybersecurity capabilities span risk management and transformation, cyber digital transformation, threat management, cyber operations, identity and data management, and integration and innovation, helping organisations realize stronger, simpler and more cost-efficient cybersecurity programs that support business requirements and outcomes. At Optiv, we are modernizing cybersecurity to enable clients to innovate their consumption models, integrate infrastructure and technology to maximize value, achieve measurable outcomes, and realize complete solutions and business alignment. For more information about Optiv, please visit us at www.optiv.com .

Link:

ClickThru

Social Media:

https://www.facebook.com/OptivInc

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Incyte Announces Positive CHMP Opinion for Zynyz® (retifanlimab) for First-Line Treatment of Advanced Squamous Cell Carcinoma of the Anal Canal (SCAC)30.1.2026 15:29:00 CET | Press release

Pending the European Commission decision, Zynyz® (retifanlimab) in combination with carboplatin and paclitaxel (platinum-based chemotherapy) will be the first PD-1 immunotherapy treatment for patients with advanced squamous cell carcinoma of the anal canal (SCAC) in EuropeGlobally, the prevalence of SCAC is estimated at around 1 or 2 cases per 100,000 people, with a higher incidence in women than in men1,2,3The Committee for Medicinal Products for Human Use (CHMP) positive opinion is based on data from the Phase 3 POD1UM-303/InterAACT2 trial which showed patients with advanced SCAC achieved significantly improved progression-free survival with Zynyz in combination with carboplatin and paclitaxel as a first-line treatment4 Incyte (Nasdaq:INCY) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has issued a positive opinion recommending the approval of Zynyz® (retifanlimab) in combination with carboplatin and paclitaxel (

Mediawan to Acquire The North Road Company, Creating a New Global Independent Content Platform30.1.2026 13:32:00 CET | Press release

Mediawan, the leading independent European studio led by Pierre-Antoine Capton, co-founded by Capton, Xavier Niel and Matthieu Pigasse, today announced the signing of an agreement to acquire The North Road Company (“North Road”), the preeminent independent U.S.-based studio founded by Peter Chernin. The combination creates one of the world’s largest independent studios with major creative hubs in the five continents and capabilities spanning all genres, formats and audiences. Together, Mediawan and North Road will have a stronger ability to accelerate the development of powerful IP, foster fresh creative synergies through format adaptations and co-production opportunities, and deliver ever greater value to viewers, talent and partners worldwide. The acquisition brings together two of the most dynamic independent studios in the sector with world-class creative talent, premium IP, and the scale to deliver content at the highest level. In an industry undergoing significant consolidation,

BrightSign Powers Intelligent Signage Experiences at ISE 202630.1.2026 09:00:00 CET | Press release

The Latest Players and AI Capabilities Drive Captivating, Personalized, and Interactive Signage With more industries embracing the power of visual storytelling, BrightSign, the provider of the most advanced, capable, and trusted digital media players and operating system, will showcase the latest developments in digital signage technology at ISE 2026 in Barcelona, Spain from February 3-6, 2026. BrightSign’s latest innovations come to life at booth #4S-150 through interactive real-world demos featuring retail, QSR, transportation, and corporate use cases. Visitors can test new AI-powered object detection capabilities of BrightSign players, allowing them to pick up an object and see the content on the screen respond immediately. Booth activations will be powered by BrightSign’s reliable platform including bsn.Control, BrightSignOS™, brightAuthor connected, and its global partner ecosystem. “In today’s immersive, personalized and visual world, the stakes have never been higher for powerfu

Candela Ushers in a New Era of Aesthetic Innovation at IMCAS Paris With the Launch of the Glacē™ System30.1.2026 08:30:00 CET | Press release

Iconic Vbeam® Pro and Matrix™ Systems showcased ahead of broader commercial availability Candela, a global leader in energy-based aesthetic technologies, today announced the European launch of the Glacē™ System, a facial treatment platform that signals a bold new chapter for the company and the future of aesthetic medicine. In addition to the launch of the Glacē System, Candela will also showcase its Matrix system for radiofrequency-based skin renewal and its iconic Vbeam® Pro vascular treatment platform at IMCAS 2026. Both Matrix and VBeam Pro platforms are currently available in select EMEA markets and are expected to be comprehensively launched shortly, further strengthening Candela’s leadership in the energy-based device market. Unveiled at the IMCAS World Congress 2026, these launches underscore Candela’s continued commitment to delivering innovative, science-backed treatment solutions for high-demand patient needs. Candela leads the industry in clinical efficacy and safety, suppo

Merz Therapeutics Appoints Dan Staner as President, Region Europe30.1.2026 08:00:00 CET | Press release

Merz Therapeutics today announced the appointment of Dan Staner as President, Region Europe, effective February 1, 2026. In this role, Dan will oversee the company’s European business and drive regional growth. Dan will report directly to Merz Therapeutics Chief Executive Officer, Stefan König, and will join the Therapeutics Executive Team. His appointment reflects the company’s continued commitment to strengthening its leadership capabilities and accelerating its growth strategy across key European markets.​ “Dan brings a strong track record of building and scaling biopharmaceutical businesses across Europe,” said Stefan König, CEO of Merz Therapeutics. “His deep commercial, strategic, and regional leadership experience will be instrumental in advancing our growth ambitions, expanding patient access to our therapies, and further strengthening our presence in Europe. We are very pleased to welcome Dan to Merz Therapeutics.”​ Throughout his career, Dan has held senior leadership roles i

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye